loading

Summit Therapeutics Inc (SMMT) 最新ニュース

pulisher
Dec 13, 2025

Trading Systems Reacting to (SMMT) Volatility - news.stocktradersdaily.com

Dec 13, 2025
pulisher
Dec 11, 2025

Citi Asserts Buy Rating on Summit Therapeutics Inc. (SMMT) on Pipeline Development - Yahoo Finance

Dec 11, 2025
pulisher
Dec 11, 2025

Citi asserts buy rating on Summit Therapeutics Inc. (SMMT) on pipeline development - MSN

Dec 11, 2025
pulisher
Dec 11, 2025

Has Summit Therapeutics Rally Left Enough Upside After 448.6% Surge and DCF Upswing? - Yahoo Finance

Dec 11, 2025
pulisher
Dec 09, 2025

2 Stocks Up Over 600% in the Past 3 Years With More Room to Run - Finviz

Dec 09, 2025
pulisher
Dec 09, 2025

U.S. Markets Ended Tuesday Mixed As Galaxy Digital Led, Summit Therapeutics Lagged - Barron's

Dec 09, 2025
pulisher
Dec 09, 2025

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility - ts2.tech

Dec 09, 2025
pulisher
Dec 09, 2025

Summit Therapeutics (NASDAQ:SMMT) Shares Down 4.4%Here's Why - MarketBeat

Dec 09, 2025
pulisher
Dec 09, 2025

Duggan buys Summit Therapeutics (SMMT) shares worth $5.9m By Investing.com - Investing.com Nigeria

Dec 09, 2025
pulisher
Dec 08, 2025

Norges Bank Invests $29.58 Million in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 08, 2025
pulisher
Dec 07, 2025

New York State Common Retirement Fund Buys 227,513 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Dec 07, 2025
pulisher
Dec 06, 2025

Schroder Investment Management Group Sells 89,090 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

State Board of Administration of Florida Retirement System Boosts Stake in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Dec 05, 2025
pulisher
Dec 05, 2025

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? - Finviz

Dec 05, 2025
pulisher
Dec 05, 2025

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? - The Motley Fool

Dec 05, 2025
pulisher
Dec 05, 2025

Why analysts upgrade Summit Therapeutics Inc. stockJuly 2025 Earnings & Weekly Chart Analysis and Guides - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Summit Therapeutics Inc. (SMMT) Options Chain - Yahoo! Finance Canada

Dec 05, 2025
pulisher
Dec 04, 2025

1 Reason I'll Never Sell Vertex Pharmaceuticals Stock - AOL.com

Dec 04, 2025
pulisher
Dec 04, 2025

Summit Therapeutics (NASDAQ:SMMT) Trading 9.2% HigherShould You Buy? - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Can Summit Therapeutics Inc. stock maintain operating marginsWeekly Gains Report & AI Powered Market Trend Analysis - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Summit Therapeutics Earnings Notes - Trefis

Dec 04, 2025
pulisher
Dec 03, 2025

Don't Buy Summit Therapeutics Until This Big Thing Happen - Nasdaq

Dec 03, 2025
pulisher
Dec 02, 2025

Widening Q3 Losses and Insider Buying Might Change The Case For Investing In Summit Therapeutics (SMMT) - Yahoo Finance

Dec 02, 2025
pulisher
Dec 02, 2025

Summit Therapeutics (SMMT): Valuation Check After Weak Q3 2025 Results and Insider Share Purchases - Yahoo Finance

Dec 02, 2025
pulisher
Dec 02, 2025

How Summit Therapeutics Inc. (SMMT) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Dec 02, 2025
pulisher
Dec 02, 2025

SMMT: Four positive phase 3 trials and accelerated timelines position the pipeline for NSCLC market leadership - TradingView

Dec 02, 2025
pulisher
Dec 02, 2025

XTX Topco Ltd Makes New $925,000 Investment in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

2 Monster Stocks in the Making to Buy and Hold - The Globe and Mail

Dec 02, 2025
pulisher
Dec 02, 2025

Summit Therapeutics: InvestingPro’s Fair Value model predicted 37% downside By Investing.com - Investing.com Nigeria

Dec 02, 2025
pulisher
Dec 01, 2025

Summit Therapeutics (SMMT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Nov 29, 2025

33,096 Shares in Summit Therapeutics PLC $SMMT Acquired by Inceptionr LLC - MarketBeat

Nov 29, 2025
pulisher
Nov 27, 2025

Rhenman & Partners Asset Management AB Makes New Investment in Summit Therapeutics PLC $SMMT - MarketBeat

Nov 27, 2025
pulisher
Nov 27, 2025

Summit Therapeutics PLC (NASDAQ:SMMT) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

WE Convention 2025: Dr. Maky Zanganeh, Co-CEO and President, Summit Therapeutics - Entrepreneur

Nov 26, 2025
pulisher
Nov 26, 2025

January 2026 Options Now Available For Summit Therapeutics (SMMT) - Nasdaq

Nov 26, 2025
pulisher
Nov 25, 2025

Summit Therapeutics Inc. (SMMT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 25, 2025
pulisher
Nov 25, 2025

Cynosure Group LLC Buys Shares of 18,609 Summit Therapeutics PLC $SMMT - MarketBeat

Nov 25, 2025
pulisher
Nov 24, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Nov 24, 2025
pulisher
Nov 23, 2025

40,169 Shares in Summit Therapeutics PLC $SMMT Acquired by Neo Ivy Capital Management - MarketBeat

Nov 23, 2025
pulisher
Nov 21, 2025

(SMMT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Nov 21, 2025
pulisher
Nov 20, 2025

Summit C-Suite Risks Success, Akeso Wins Either Way (OTCMKTS:AKESF) - Seeking Alpha

Nov 20, 2025
pulisher
Nov 20, 2025

Jefferies Cuts Summit Therapeutics (SMMT) Price Target, Keeps Buy Rating - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

ProShare Advisors LLC Sells 25,455 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Nov 20, 2025
pulisher
Nov 19, 2025

Is Summit Therapeutics Inc. building a consolidation baseMarket Rally & Weekly Top Stock Performers List - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What MACD and RSI say about Summit Therapeutics Inc.Gap Up & Weekly Chart Analysis and Trade Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Summit: A Cautious Bet Backed By Anti-VEGF & Insider Buying (NASDAQ:SMMT) - Seeking Alpha

Nov 19, 2025
pulisher
Nov 19, 2025

Has Summit Therapeutics Inc. found a price floorJuly 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Wolfe Research Initiates Coverage of Summit Therapeutics (SMMT) with Peer Perform Recommendation - Nasdaq

Nov 18, 2025
pulisher
Nov 18, 2025

Summit Therapeutics at Jefferies London: Strategic Progress in Cancer Trials By Investing.com - Investing.com Canada

Nov 18, 2025
pulisher
Nov 18, 2025

Wolfe Research Initiates Coverage on SMMT with 'Peer Perform' Ra - GuruFocus

Nov 18, 2025
$38.53
price up icon 0.42%
$98.38
price down icon 0.32%
$31.57
price up icon 0.83%
$93.57
price down icon 0.31%
biotechnology ONC
$300.09
price down icon 5.87%
$196.92
price down icon 1.22%
大文字化:     |  ボリューム (24 時間):